Back
TriSalus Life Sciences, Inc. 10K Form
Sell
50
TLSI
TriSalus Life Sciences, Inc.
Last Price:
$6.72
Seasonality Move:
29.79%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TLSI News And Ratings
See the #1 stock for the next 7 days that we like better than TLSI
TLSI Financial Statistics
Sales & Book Value
| Annual Sales: | $29.4M |
|---|---|
| Cash Flow: | $-3.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.54 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.01610 |
|---|---|
| Net Income (TTM): | $-39.6M |
| Gross Margin: | $24.6M |
| Return on Equity: | 0% |
| Return on Assets: | -125.38% |
TriSalus Life Sciences, Inc. Earnings Forecast
Key TriSalus Life Sciences, Inc. Financial Ratios
-
The Gross Profit Margin over the past 5 years for TLSI is 83.53%.
-
The Selling, General & Administrative Expenses for TLSI have been equal to 148.84% of Gross Profit Margin.
-
The Research & Development expenses have been 60.10% of Revenue.
-
The Net Earning history of TLSI is -102.09% of Total Revenues.
-
Per Share Earnings over the last 5 years have been positive in 3 years.
TriSalus Life Sciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TLSI |
| Website: | trisaluslifesci.com |
Debt
| Debt-to-Equity Ratio: | -1.28 |
|---|---|
| Current Ratio: | 3.05 |
| Quick Ratio: | 2.54 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TLSI Technical Analysis vs Fundamental Analysis
Sell
50
TriSalus Life Sciences, Inc. (TLSI)
is a Sell
Is TriSalus Life Sciences, Inc. a Buy or a Sell?
-
TriSalus Life Sciences, Inc. stock is rated a SellThe current TriSalus Life Sciences, Inc. [TLSI] share price is $6.70. The Score for TLSI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.